Institutions / Soleus Capital Management, L.P.
Soleus Capital Management, L.P.
CIK 1802630 · Institution · as of Dec 31, 2025
Portfolio value
$2.36B
Positions
94
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 94 →
| Company | Value | % of portfolio |
|---|---|---|
| Krystal Biotech, Inc. | $232.01M | 9.8% |
| Celcuity Inc.CELC | $180.36M | 7.7% |
| NovoCure Ltd | $110.30M | 4.7% |
| Praxis Precision Medicines, Inc. | $106.98M | 4.5% |
| TG Therapeutics Inc | $93.58M | 4.0% |
| Dexcom Inc | $86.09M | 3.7% |
| BioMarin Pharmaceutical Inc | $78.45M | 3.3% |
| Globus Medical Inc | $77.44M | 3.3% |
| Beta Bionics, Inc. | $77.23M | 3.3% |
| Amicus Therapeutics Inc | $74.15M | 3.1% |
| Twist Bioscience Corp | $59.06M | 2.5% |
| Organogenesis Holdings Inc.ORGO | $51.73M | 2.2% |
| Syndax Pharmaceuticals Inc | $47.21M | 2.0% |
| Mirum Pharmaceuticals, Inc. | $45.31M | 1.9% |
| Insulet Corp | $42.64M | 1.8% |
| NeuroPace Inc | $41.74M | 1.8% |
| Axogen, Inc. | $39.50M | 1.7% |
| Ani Pharmaceuticals Inc | $38.38M | 1.6% |
| Alkermes plc. | $37.00M | 1.6% |
| LivaNova PLC | $34.92M | 1.5% |
| Gsk PLC | $31.34M | 1.3% |
| Geron Corp | $30.74M | 1.3% |
| United Therapeutics Corp | $29.23M | 1.2% |
| Immunovant, Inc.IMVT | $28.22M | 1.2% |
| Vaxcyte, Inc. | $28.10M | 1.2% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.